General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.
1. At a Glance
The company crushed ₹2,109 Cr in revenue in FY26 (+13.3% YoY) but net profit fell to ₹25.2 Cr from ₹46.5 Cr the year before.
This gap reveals the cost story: raw material, cane pricing, and inventory holding dragged margins down.
Meanwhile, the credit rating fell two notches in January 2026 (from CARE A- to CARE BBB+), citing muted profitability and elevated inventory.
Three plants, one integrated story—sugar, ethanol, country liquor—but cyclicality and weather remain the deck-shufflers.
The multiple sits at 30.4x earnings against a peer median of 17.98x; the company is testing patience on the profitability side.
Why it matters: growth in revenue sounds good; profit collapse tells a different tale.
2. Introduction
Dhampur Bio Organics was born in May 2022 from a demerger of the undivided Dhampur Sugar Mills, carved into equal halves between two branches of the Goel family.
DBOL got three plants in western-central Uttar Pradesh—Asmoli, Mansurpur, and Meerganj—with combined cane-crushing capacity of 29,500 tonnes per day.
The company is forward-integrated: sugar feeds into a distillery (312.5 KLPD on molasses), which feeds into ethanol and country liquor; power generation runs at 95.5 MW cogeneration.
Promoters hold 50.65%, with Gautam Goel (now Chairman & CEO, redesignated May 2026) and his family in command. Vice Chairman Ashwani Kumar Gupta brings 40 years in finance and capital markets.
A major move landed in April 2026: the company signed a JV with Orgonew (74/26 split) and approved a slump sale of the Meerganj plant for ₹305 Cr—a deliberate restructuring that signals exit from one footprint.
Late Chairman Vijay Kumar Goel died on May 10, 2026, after 65 years in sugar: he had chaired ISMA and the Indian Sugar Exim Corporation.
3. Business Model: WTF Do They Even Do?
Sugar (80% of FY26 gross revenue): DBOL mines sugarcane into refined sugar, pharma-grade sugar (FSSAI-approved), white sugar, and retail packets. It sold 3.63 lakh tonnes in FY26 at an average realisation of ₹41,021 per tonne—up from ₹39,317 the prior year.
Production dropped to 3.54 lakh tonnes from 4.23 lakh tonnes, a victim of red-rot infestation in UP’s cane belts and lower recovery rates (10.74% in FY26 vs 10.32% prior). The company had to rely on inventory: it cleared 2.20 lakh tonnes of stored sugar.
Biofuels & Spirits (16% of FY26): Ethanol is the lever. DBOL makes it from syrup, B-heavy molasses, and C-heavy molasses. It also operates a dual-feed distillery (100 KLPD) that can crush sugarcane grain, newer machinery. In FY26, ethanol production was 68.09 Mn bulk litres; sales were 52.67 Mn BL at ₹59.34 per litre. The stock sits at 6.59 Mn BL. Ethanol pricing has stalled: ₹65.6/litre for juice-based, ₹60.7/litre for B-heavy molasses—unchanged since ESY23. Rising cane costs have pinched margins. CARE Ratings flagged this: segment EBIT margin fell from 24% in FY24 to 16% in FY25.
Country Liquor (4% of FY26): To meet sugar levy obligations, DBOL diverts molasses into Indian Made Indian Liquor (IMIL). FY26 sales were 4.41 Cr cases at ₹281.58 per case net of excise. The segment is a margin-holder (14.92% EBIT margin) but demand is flat.
Power (1% of FY26): 95.5 MW cogeneration. FY26 exports: 90.56 Mn units at ₹4.43/unit (+29% realisation YoY). The windfall is modest; generation itself fell to 238.38 Mn units from 233.27 prior.
The model is clever: sugar buys in bulk seasonally; ethanol and power cushion the swing. But when cane costs rise 10%, realisation creeps 1%—leverage compresses.
4. Financials Overview
Figures are consolidated, in ₹ crore.
| Metric | Latest (Mar-26) | Prior Year (Mar-25) | YoY Change |
|---|---|---|---|
| Revenue | 2,109.25 | 1,861.54 | +13.3% |
| EBITDA | 162.01 | 143.64 | +12.8% |
| PAT | 25.18 | 14.69 | +71.4% |
| EPS (₹) | 3.79 | 2.21 | +71.5% |
Q4FY26 Snapshot (January–March 2026):
Revenue came in at ₹552.44 Cr (+19% YoY), lifted by sugar sales volume. EBITDA was ₹102.44 Cr (18.54% margin). PAT: ₹46 Cr (8.33% margin).
The quarterly rebound masks the full-year strain: sugar and country liquor held up; ethanol contracted 18.8% YoY.
From the earnings call (May 2026): Management flagged ₹305 Cr from the Meerganj slump sale (pending completion), which will de-lever the balance sheet by ~0.18x. The company also revealed that the January income tax search (Oct–Nov 2025) found no immediate plant impact.
5. Market Expectations & Historical Multiples
This section describes how the market is currently pricing the company and how that compares with its own history and peer group. It is descriptive, not predictive.
| Metric | Current | Historical Average (5-yr) | Peer Median |
|---|---|---|---|
| P/E | 30.4x | 26.8x | 17.98x |
| EV/EBITDA | 11.0x | — | — |
| P/B | 0.74x | — | 0.92x |
| ROE | 2.47% | 6.05% | 7.02% |
| ROCE | 4.88% | — | 7.54% |
The market currently pays 30.4x earnings for DBOL, above its own 5-year average of 26.8x and well above the peer median of 17.98x. ROE has collapsed to 2.47% from a 5-year average of 6.05%; ROCE sits at 4.88%, half the peer set. P/B of 0.74x is below the peer median of 0.92x.
This contrast—elevated P/E paired with depressed P/B and ROCE—flags what the market appears to be pricing in: a temporary earnings trough, not fundamental decay. Recovery in margins (once red-rot clears and cane costs normalise) would justify the premium; stalled recovery would erase it. Neither outcome is priced as certainty.
6. What’s Cooking
Recent material events and reported sizes (facts, not predictions):
- Meerganj Plant Sale (April 20, 2026): Board approved slump sale of the Meerganj unit for ₹305 Cr to an unnamed buyer. Meerganj represents ~9,000 TCD (30% of total crushing capacity) and 800 TPD LQW sugar. Expected to close in H1FY27.
- Sonitron Chemicals Acquisition (April 20, 2026): Board approved acquisition of Sonitron Limited, a promoter entity making chemicals, for an unspecified consideration. Not yet closed. Intent: backward integration into sugar additives.
- UAE Subsidiary Incorporation (February 26, 2026): Board approved incorporation of a 100% UAE subsidiary with initial investment of AED 7.345 Mn (~USD 2 Mn). Export play, possibly for sugar and ethanol.
- Rakesh Agarwal Resignation (May 31, 2026): Vice President–Bottling Operations stepped down. No explanation given. Bottling implies country liquor upstream moves.
- Income Tax Search (October–November 2025): IT Department conducted search at corporate and manufacturing units for 6 days. No plant disruption, no FIRs. Management states no coercive action initiated.
- CARE Ratings Downgrade (January 13, 2026): Downgraded from CARE A- to CARE BBB+ (long-term). Reason: “continued subdued operational performance…low recovery rates…red rot infestation.” Interest coverage fell to 1.65x from prior levels.
- Dividend Announced (May 30, 2026): Board approved final dividend of ₹1.50/share (40% payout), totalling ~₹9.96 Cr. Full-year payout ratio: 40% (down from 56% prior year as profits compressed).
7. Balance Sheet
| Item | Mar-24 | Mar-25 | Mar-26 |
|---|---|---|---|
| Total Assets | 2,312.81 | 2,397.53 | 2,322.13 |
| Equity (Shares + Reserves) | 1,011.47 | 1,011.74 | 1,026.64 |
| Borrowings | 1,056.95 | 1,162.34 | 1,060.46 |
| Other Liabilities | 244.39 | 223.45 | 235.03 |
| Assets = Liabilities? | ✓ | ✓ | ✓ |
Reading the sheet:
Debt has fallen by ₹101.88 Cr (to ₹1,060.46 Cr) but equity barely moved. Debt-to-equity stands at 1.03x, down from 1.15x. The company repaid ₹78.97 Cr in FY26 and availed ₹60 Cr in new debt—net outflow. Working capital loans remain elevated at ~₹844 Cr (up from ₹806 Cr) due to inventory.
Three sarcastic observations:
- The inventory elephant: Sugar inventory sits at 2.20 lakh tonnes valued at ₹827 Cr as of March 2026, nearly 40% of total working capital. Clearing it depends on price and sales quotas. In a zero-growth market, inventory is a hostage to luck.
- Cogeneration capex trap: Net block (fixed assets) rose to ₹1,130.68 Cr from ₹1,076.21 Cr. CWIP dropped to ₹0.98 Cr from ₹78.94 Cr, meaning capex phase is dormant. But maintaining 95.5 MW of boilers and turbines costs serious cash. Capex silence is not savings.
- Cash is tight: Cash and bank balance: ₹36.16 Cr. Against ₹1,060 Cr debt, that’s 1.2 weeks of service. Working capital facilities are at 80% utilization (as of Sept 2025).
Net cash: ₹36.16 Cr cash minus ₹1,060.46 Cr debt = -₹1,024.3 Cr net debt. The company is a net borrower.
8. Cash Flow: Sab Number Game Hai
| Year | Operating | Investing | Financing |
|---|---|---|---|
| FY24 | -101.33 | -166.29 | 169.56 |
| FY25 | 129.57 | -145.47 | 18.79 |
| FY26 | 219.86 | -41.54 | -178.49 |
The story:
FY24 was a ditch: operations burned ₹101 Cr (red-rot, low cane). Financing came to the rescue (+₹169 Cr from new debt).
FY25 turned around: operations generated ₹129 Cr. But capex came alive (₹145 Cr outflow to Meerganj and capacity upgrades). Financing was neutral.
FY26 is the pivot: operations roared back to ₹219.86 Cr (from higher sugar realisations and lower interest post-debt repayment). Capex shrank to ₹41.54 Cr (Meerganj sale decision halted fresh investment). Financing was a ₹178 Cr outflow—debt repayment and dividend outlay.
The wisdom: When operations finally generate cash, the first reflex is to pay down debt. It’s not reinvestment greed; it’s balance-sheet hygiene. DBOL’s CFO is moving the levers in the right order.
9. Ratios: Sexy or Stressy?
| Ratio | FY26 Value | Reading |
|---|---|---|
| ROE | 2.47% | The equity is part-time. A ₹1,027 Cr net worth generated ₹25.18 Cr net profit. Returns are below cost of equity (~8-10%). Shareholders’ capital is uncompensated. |
| ROCE | 4.88% | Capital employed (₹1,027 Cr equity + ₹1,060 Cr debt = ₹2,087 Cr) earned ₹101.8 Cr EBIT. That’s a 4.9% return, half of cost of capital (8-9%). The business is destroying value on an incremental basis. |
| P/E | 30.4x | Against sector median of 17.98x, DBOL is priced at a 69% premium. At ROCE of 4.88%, no growth justifies this. Market may be mispricing hope. |
| PAT Margin | 1.20% | Bottom-line margin is paper-thin. A ₹2,109 Cr top line yields ₹25.18 Cr profit. Every rupee of revenue keeps 1.2 paise. The company is operationally weak (EBITDA margin 7.78% is decent; profit deflation happens on the downside—taxes, interest, one-time items). |
| D/E | 1.03x | Debt is 103% of equity. Against a sugar industry average around 0.50–0.80x, this is elevated. The company is overleveraged relative to earnings stability. |
10. P&L Breakdown: Show Me the Money
| Year | Revenue | EBITDA | PAT |
|---|---|---|---|
| FY24 | 1,864.44 | 140.38 | 46.49 |
| FY25 | 1,861.54 | 143.64 | 14.69 |
| FY26 | 2,109.25 | 162.01 | 25.18 |
Trajectory:
Revenue stalled in FY25 (flat vs FY24: ₹1,861 Cr) due to red-rot and lower cane crushing. FY26 rebounded +13.3% to ₹2,109 Cr on better crushing days and inventory drawdown.
EBITDA inched up: FY24 ₹140 Cr → FY25 ₹143.64 Cr → FY26 ₹162.01 Cr. The margin: 7.5% → 7.7% → 7.78%. Operating leverage is flat. Sugar is a low-multiple business.
Net profit tells the worse story: FY24 ₹46.49 Cr → FY25 ₹14.69 Cr (crash, one-time adjustments) → FY26 ₹25.18 Cr (rebound, but still 46% below FY24). Interest and tax ate the gap. Interest expense is ₹62.98 Cr in FY26 on ₹1,060 Cr debt; each ₹100 Cr of revenue service ₹3 Cr in interest. This is a company where financing costs are material and profitability is razor-thin.
11. Peer Comparison
| Company | Revenue (₹ Cr) | PAT (₹ Cr) | P/E |
|---|---|---|---|
| Balrampur Chini | 6,271 | 378.46 | 30.14x |
| Triveni Engineering | 6,290 | 279.09 | 30.47x |
| Bannari Amm. Sugar | 1,917 | 147.92 | 30.65x |
| Dalmia Bharat | 3,618 | 237.81 | 11.15x |
| Dhampur Bio | 2,109 | 25.18 | 30.4x |
| Peer Median | 2,848 | 29.48 | 17.98x |
DBOL is 26% smaller than the peer median by revenue but 14% smaller by profit. The reason: OPM of 6.2% (Dhampur) vs 7.27% (median). Smaller scale + weaker margins = lower absolute profit.
The P/E is 30.4x—clustered with Balrampur (30.14x), Triveni (30.47x), and Bannari (30.65x), all at the high end. But Dalmia (11.15x) is an outlier, possibly because it has higher ROCE (~8.3%) and more diversified revenue. Dhampur’s multiple sits at a premium to the median despite inferior returns—a crowding phenomenon, or market hopes for a turnaround.
12. Miscellaneous: Shareholding & Promoters
| Holder | % |
|---|---|
| Promoters | 50.65% |
| FII | 0.54% |
| DII | 0.79% |
| Public (incl. NRI) | 47.87% |
Promoter structure:
- Sonitron Limited (Gautam Goel family entity): 17.28%
- Shudh Edible Products Pvt Ltd: 16.90%
- Gautam Goel (individual): 11.84%
- Deepa Goel (individual): 4.52%
- Bindu Vashist Goel: 0.12%
Gautam Goel, now Chairman & CEO (from May 31, 2026), has long been a force. He was President of ISMA in 2025 and led the Sonitron acquisition. His father, Vijay Kumar Goel (now deceased), was a legend—65 years in sugar, ISMA chief, deeply woven into government sugar policy circles.
The promoter roast: The family has been in sugar since 1933, which is not luck. But the current cycle—red-rot, policy inertia, ethanol price caps—is older men’s problems. Restructuring (Meerganj sale) suggests Gautam is thinking exit or cash-out on one asset. The ₹305 Cr Meerganj deal, if closed, will give them ~₹155 Cr of cash (50.6% stake). That’s re-mortgage, not growth.
No pledging of shares (0.00% pledged), which is good. FII ownership collapsed from 4.81% in mid-2023 to 0.54% now—exodus, not rotation.
13. Corporate Governance: Angels or Devils?
Auditors: B S R & Co. LLP (Big 4, no flags).
Board: 8 directors—Gautam Goel (Chairman & CEO, Managing Director until May 2026, now elevated), Ashwani Kumar Gupta (Vice Chairman, independent, 40 years in finance), Sandeep Kumar (Non-Exec, 40+ years ops), Bindu Vashist Goel (Non-Exec, lawyer, CSR lead), Ruchika Amrish Mehra Kothari (Non-Exec Independent, textile/wool), Vishal Saluja (Non-Exec Independent, hedge fund manager), Samir Thukral (Non-Exec Independent, commodity trader), Kishor Shah (Non-Exec Independent, CA, ex-sugar CFO). Mix looks competent but long on generalists and commodity traders, short on growth technologists.
Related-party transactions: None flagged in recent annex.
Resignations:
- VP Bottling Operations Rakesh Agarwal (May 31, 2026)—no stated reason.
- VP IT Naresh Kumar Pathak (March 11, 2026)—no stated reason.
- Two departures in 3 months suggest churn, not crisis, but morale whiff.
Income Tax Search (Oct–Nov 2025): IT Dept. searched corporate and manufacturing units for 6 days. CARE Ratings notes: “no immediate impact on plant operations or banking…no coercive action initiated.” But the reputational scar lingers. SEBI-listed companies do not welcome tax department searches, even if procedural.
Dividend History: Paid 21% in FY23, 36% in FY24, 56% in FY25, and 40% in FY26. The company returned profit in good years and cut when profits fell—classic sugar industry behavior.
14. Industry Roast & Macro Context
Sugar is a commodity: prices are set by global supply-demand and domestic government quotas. India produces 30 Mn tonnes annually; global supply is tight. Export restrictions, MSP fixation, and cane pricing (SAP set by UP govt) are policy levers, not company decisions.
Red-rot infestation in UP: A fungal disease decimated cane in western UP in FY25–FY26, lowering recovery rates from 10.32% to 9.8%. Breeding disease-free cane takes 2–3 seasons. DBOL is replanting; results are 12–18 months away.
Ethanol price cage: E20 blending is the government’s push; DBOL needs it to absorb molasses. But ethanol prices have been static since ESY23 (Oct 2022) at ₹65.6/litre for juice-derived and ₹60.7/litre for B-heavy molasses—while cane costs rose 15–20%. Segment margins have collapsed from 24% to 16%. Unless the government hikes ethanol prices or extends blending mandates (post-20%), distillery profitability is capped.
Working capital misery: Sugar mills must buy cane seasonally (Nov–Apr crushing) and sell sugar year-round. Inventory holding is 224 days (up from 160 in FY23). Government sugar quotas restrict sales, forcing mills to hold stock. DBOL’s inventory is ₹827 Cr; financing it at 8–9% costs ₹66–74 Cr per annum—nearly 3x the net profit.
Power exports are a trickle: Cogeneration was meant to be the hedge. DBOL exports 90.56 Mn units (FY26) at ₹4.43/unit—₹401 Cr revenue contribution. But it’s 19% of total and faces grid absorption limits in UP.
Does DBOL roast the sector? No. It is the sector’s pinch-points made tangible: policy cap on ethanol pricing, government sugar quotas, weather-driven cane loss, and working capital strangulation. A well-run sugar company can trim fat; an exceptional one can diversify. DBOL is neither. It is a sugar company trying to be a bioenergy company but hamstrung by legacy constraints.
15. EduInvesting Verdict
| Strengths | Weaknesses |
|---|---|
| Integrated operations (sugar + ethanol + power + spirits) reduce single-commodity risk. | ROE of 2.47% and ROCE of 4.88% both below cost of capital; value is being destroyed on an incremental basis. |
| Forward-integrated distillery (312.5 KLPD) allows molasses-to-ethanol margin capture. | Revenue growth (+13.3%) masked by profit collapse (71% rebound from FY25 lows is not recovery; it’s climbing out of a crater). |
| Experienced promoters with 93 years in sugar; deep government and ISMA ties. | Debt-to-equity of 1.03x is elevated for a cyclical business; net debt is ₹1,024 Cr against ₹25 Cr net profit (41-year payback at FY26 rates). |
| Balance sheet holds no pledged shares; independent board structure. | P/E of 30.4x is 69% above peer median despite inferior returns; multiple hangs on recovery hope, not current earnings power. |
| Meerganj sale (₹305 Cr) and Sonitron acquisition signal active rebalancing. | Ethanol prices frozen since Oct 2022; rising cane costs erode margins; distillery EBIT margin fell from 24% to 16% in 18 months. |
| Inventory at ₹827 Cr (35% of total liabilities); financing cost is material; quota-bound sales mean slow clearing. | |
| Red-rot infestation in cane; recovery rates recovering at 2–3 year horizons. |
| Opportunities | Threats |
|---|---|
| E20 blending expansion (India at 19.24% of ESY25 target, aiming for 20% by ESY26) could lift ethanol offtake if prices rise. | Government policy regime: SAP (state-advised price) of cane, MSP of sugar, export quotas, and ethanol pricing are not company variables. Adverse policy shifts can crater returns. |
| Cane disease clearing (new disease-free varieties) should raise recovery rates to 10.5%+ by FY27–FY28. | Cyclicality: global sugar surplus, domestic quota restrictions, and weather volatility are structural risks. |
| Meerganj sale de-levers balance sheet by ~0.18x, freeing ₹155 Cr cash (at current stake) for dividend or reinvestment. | Demand stagnation: sugar consumption in India is 0.8% growth annually; exports are policy-gated; spirits are niche. |
| Sonitron acquisition (chemicals) hints at backward integration, possibly into sugar additives (pH reducers, decolorizers). | Agro-climatic exposure: drought or excess rain in UP breaks crushing days and recovery; FY25 saw crushing days drop to 145 from 169. |
| Interest coverage of 1.65x is tight; further downturns could breach covenants. |
The Closing Observation:
A balance sheet with nothing to hide and a multiple with everything to prove—this is Dhampur Bio Organics in June 2026. Revenue has rebounded, dividend is steady, board is mixed-competent. But the ₹1,024 Cr net debt sits atop a ₹25 Cr annual profit, making the company a refinancing play, not a growth story. The P/E of 30.4x bets that margins will recover faster than the 5–8% cane cost inflation and that government ethanol pricing will move. Neither is certain. The company has the structure to win in a benign scenario and the leverage to lose badly in a mean one. For now, it is a call on macro, not management.